Evidence map›Paper›PMID 21861811›Full record

ReviewMini reviews in medicinal chemistry2011

Most recent developments and modifications of 14-alkylamino and 14-alkoxy-4,5-epoxymorphinan derivatives.

L Stavitskaya, A Coop

Abstract readReview
In one paragraph

Review in Mini reviews in medicinal chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. ACS omega · 2021
    Article
  4. Frontiers in pharmacology · 2018
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

L StavitskayaDepartment of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA.
A Coop

Funding

OPIOIDS WITH DELTA ANTAGONIST AND MU AGONIST ACTIVITYR01DA013583 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI COOP, ANDREW · 2001 to 2012
$2.5M
NIDA NIH HHS DA-13583NIDA NIH HHS R01 DA013583
6 · The paper itself

Abstract

The 14-position of natural opiates (e.g. morphine) are unsubstituted, however synthetic approaches have uncovered that functionalizing position 14 gives rise to a wide range of diverse activities. This review focuses on SAR of the position, with the aim of aiding in the search for opioid analgesics with improved clinical profiles.

Indexed as

Narcotic AntagonistsAnimalsHumansMorphinansPainReceptors, OpioidStructure-Activity Relationship4,5-epoxymorphinanMorphinansNarcotic AntagonistsReceptors, Opioid

Identifiers

PMID21861811
PMCPMC3401597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.